Antiretroviral adherence and the nature of HIV-associated verbal memory impairment

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 23, Issue 3, 2011, Pages 324-331

  Wright, Matthew J ^a   Woo, Ellen ^a   Foley, Jessica ^b,c,d   Ettenhofer, Mark L ^b,e   Cottingham, Maria E ^a   Gooding, Amanda L ^f   Jang, Jiah ^g   Kim, Michelle S ^h   Castellon, Steve A ^b,g   Miller, Eric N ^b,i   Hinkin, Charles H ^b,g  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Uniformed Services University of the Health Sciences   (United States)

^f FORDHAM UNIVERSITY   (United States)

^g VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^h FULLER THEOLOGICAL SEMINARY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; NEUROPROTECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECALL; VERBAL MEMORY;

EID: 80054978943     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/jnp.23.3.jnp324     Document Type: Article

References (43)

1. Hardy DJ, Hinkin CH, Levine AJ, et al: Risky decision-making assessed with the gambling task in adults with HIV. Neuropsychology 2006; 20:355-360
2. Heaton RK, Grant I, Butters N, et al: The HNRC 500: neuropsychology of HIV infection at different disease stages: HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1995; 1:231-251
3. Hinkin CH, Castellon SA, van Gorp WG, et al: Neuropsychological features of HIV disease, in A Mental Health Practitioner's Guide to the Neuropsychiatric Complications of HIV/ AIDS. Edited by van Gorp WG, Buckingham SL. New York, Oxford University Press, 1998, pp 1-41
4. Miller EN, Selnes OA, McArthur JC, et al: Neuropsychological performance in HIV-1-infected homosexual men: the Multi-center AIDS Cohort Study (MACS). Neurology 1990; 40:197-203
5. Selnes OA, Galai N, Bacellar H, et al: Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study. Neurology 1995; 45:267-275
6. Paul RH, Yiannoutsos CT, Miller EN, et al: Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuropsychiatry Clin Neu-rosci 2007; 19:283-292
7. Meyerhoff DL, Bloomer C, Cardenas V, et al: Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999; 52:995-1003
8. Woods SP, Carey CL, Troster AI, et al: Action (verb)-generation in HIV-1 infection. Neuropsychologia 2005; 43:1144-1151
9. Moore DJ, Masliah E, Rippeth JD, et al: Cortical and subcortical neurodegeneration is associated with HIV neurocogni-tive impairment. AIDS 2006; 20:879-887
10. Thompson PM, Dutton RA, Hayashi KM, et al: Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T-lym-phocyte decline. Proc Natl Acad Sci USA 2005; 102:15647-15652
11. Cooper DA, Merigan TC: Clinical treatment. AIDS 1996; 10: S133-S134
12. Ferrando SJ, Rabkin JG, van Gorp W, et al: Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection. J Neuropsychiatry Clin Neurosci 2003; 15:208-214
13. McCutchan JA, Wu JW, Robertson K, et al: HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS 2007; 21:1109-1117
14. Sacktor N, Nakasuja N, Skolasky R, et al: Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 2006; 67:311-314
15. Bandaru VVR, McArthur JC, Sacktor N, et al: Associative and predictive biomarkers of dementia in HIV-1-infected patients. Neurology 2007; 68:1481-1487
16. Baldewicz TT, Leserman J, Silva SG, et al: Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. AIDS Be-hav 2004; 8:345-355
17. Robertson KR, Smurzynski M, Parsons TD, et al: The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007; 21:1915-1921
18. Robinson-Papp J, Elliott KJ, Simpson DM: HIV-related neurocognitive impairment in the HAART era. Curr HIV/AIDS Rep 2009; 6:146-152
19. Tozzi V, Balestra P, Bellagamba R, et al: Persistence of neuropsychological deficits despite long-term highly-active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J AIDS 2007; 45:174-182
20. Wright MJ, Woo E, Barclay TR, et al: The functional impact of HIV-associated neuropsychological decline, in HIV and the Brain: New Challenges in the Modern Era. Edited by Paul RH, Sacktor NC, Valcour V, et al. New York, Humana Press, 2009, pp 233-248
21. Levine AJ, Hinkin CH, Castellon SA, et al: Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav 2005; 9:355-362
22. Odiase FE, Ogunrin OA, Ogunniyi AA: Memory performance in HIV/AIDS: a prospective case-control study. Can J Neurol Sci 2007; 34:154-159
23. Ettenhofer ML, Foley J, Castellon SA, et al: Reciprocal prediction of medication adherence and neurocognition in HIV/ AIDS. Neurology 2010; 74:1217-1222
24. Gongvatana A, Woods SP, Taylor MJ, et al: Semantic clustering inefficiency in HIV-associated dementia. J Neuropsychia-try Clin Neurosci 2007; 19:36-42
25. Scott JC, Woods SP, Patterson KA, et al: Recency effects in HIV-associated dementia are characterized by deficient encoding. Neuropsychologia 2006; 44:1336-1343
26. Waldrop D, Ownby RL, Kumar M: Serial-position effects in HIV-infected injecting drug users. Int J Neurosci 2004; 114: 493-516
27. Delis DC, Peavy G, Heaton R, et al: Do patients with HIV-associated minor cognitive/motor disorder exhibit a "subcor-tical" memory profile? evidence using the California Verbal Learning Test. Assessment 1995; 2:151-165
28. White DA, Taylor MJ, Butters N, et al: Memory for verbal information in individuals with HIV-associated dementia complex. J Clin Exp Neuropsychol 1997; 19:357-366
29. Murji S, Rourke SB, Donders J, et al: Theoretically-derived CVLT subtypes in HIV-1 infection: internal and external validation. J Int Neuropsychol Soc 2003; 9:1-16
30. York MK, Franks JJ, Henry RR, et al: Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals. Psychol Med 2001; 31:1279-1291
31. Delis DC, Kramer JH, Kaplan E, et al: California Verbal Learning Test, 2nd Edition. San Antonio, TX, The Psychological Corporation, 2000
32. Wright MJ, Woo E, Schmitter-Edgecombe M, et al: The item-specific deficit approach (ISDA) to evaluating verbal memory dysfunction: rationale, psychometrics, and application. J Clin Exp Neuropsychol 2009; 31:790-802
33. Wilde MC, Boake C, Sherer M: Do recognition/free recall discrepancies detect retrieval deficits in closed-head injury? An exploratory analysis with the California Verbal Learning Test. J Clin Exp Neuropsychol 1995; 17:849-855
34. Aggleton JP, Brown MW: Interleaving brain systems for episodic and recognition memory. Trends Cogn Science 2006; 10:455-463
35. Miller RR, Matzel, LD: Retrieval failure versus memory loss in experimental amnesia: definitions and processes. Learning Mem 2006; 13:491-497
36. Ellis HC, Hunt RR: Fundamentals of Human Memory and Cognition, 3rd Edition. Dubuque, IA, Wm. C. Brown Company Publishers, 1983, pp 84-130
37. Manly JJ, Jacobs DM, Touradji P, et al: Reading level attenuates differences in neuropsychological test performance between African American and white elders. J Int Neuropsychol Soc 2002; 8:341-348
38. Delis DC, Kramer JH, Kaplan E: California Verbal Learning Test: Adult Version. San Antonio, TX, The Psychological Corporation, 1987
39. Paterson DL, Swindells S, Mohr J, et al: Adherence to pro-tease-inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30
40. Bangsberg DR, Hecht FM, Charlebois ED, et al: Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14:357-366
41. Cysique LA, Vaida F, Letemdre S, et al: Dynamics of cognitive change in impaired HIV-positive patients initiating antiretro-viral therapy. Neurology 2009; 73:342-348
42. Han S, Huettel SA, Raposo A, et al: Functional significance of striatal responses during episodic decisions: recovery or goal attainment? J Neurosci 2010; 30:4767-4775
43. Zizak VS, Filoteo JV, Possin KL, et al: The ubiquity of memory-retrieval deficits in patients with frontal-striatal dysfunction. Cogn Behav Neurol 2005; 18:198-205